Table 1.  Baseline characteristics of the subjects.

n (men/women)	96 (57/39)
Age (years)	61.5 ± 11.4
BMI (kg/m2)	25.5 ± 4.2
LDL‐C (mg/dL)	164 ± 36
HDL‐C (mg/dL)	55 ± 14
LDL/HDL ratio	3.2 ± 1.1
TG (mg/dL)	198 ± 117
HbA1c (%)	6.7 ± 1.0
AST (IU/L)	25 ± 13
ALT (IU/L)	27 ± 19
AST/ALT ratio	1.1 ± 0.4
GGT (IU/L)	50 ± 53
Antidiabetic therapy (n)
Diet only	28
Sulfonylurea	39
α‐Glucosidase inhibitor	19
Biguanide	18
Thiazolidine	18
Glinide	8
Insulin	12
Antihyperlipidemic therapy (n)
Pravastatin	2
Rosuvastatin	5
Atorvastatin	3
Pitavastatin	1
Bezafibrate	31
Fenofibrate	1

Data are the mean ± SD or the number of subjects in each group, as indicated. BMI, body massindex; LDL‐C, low‐density lipoprotein–cholesterol; HDL‐C, high‐densitylipoprotein–cholesterol; TG, triglycerides; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ‐glutamyltransferase.